Ligand validation:2HEJ

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2HEJ_EDO_A_804	80%	32%	0.096	0.945	2.45	0.32	1	-	0	0	100%	1
2HEJ_EDO_A_801	55%	34%	0.132	0.901	2.41	0.27	1	-	0	0	100%	1
2HEJ_EDO_A_805	34%	32%	0.165	0.849	2.41	0.33	1	-	1	0	100%	1
2HEJ_EDO_B_802	24%	32%	0.235	0.862	2.44	0.31	1	-	0	0	100%	1
2HEJ_EDO_A_803	2%	33%	0.206	0.496	2.4	0.32	1	-	0	0	100%	1
2IPF_EDO_A_326	84%	33%	0.097	0.959	2.33	0.36	1	-	1	0	100%	1
2IPG_EDO_A_326	72%	35%	0.137	0.961	2.29	0.32	1	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.